Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
At close: Dec 31, 2025

Helix BioMedix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2011FY 2010FY 2009FY 2008FY 20072002 - 2006
Period Ending
Dec '25 Dec '11 Dec '10 Dec '09 Dec '08 Dec '07 2002 - 2006
012149913
Upgrade
Market Cap Growth
-96.84%-8.71%56.11%-2.86%-30.00%-35.30%
Upgrade
Enterprise Value
-1021131011
Upgrade
Last Close Price
1.7575.0087.00102.00105.00150.00
Upgrade
PS Ratio
0.196.5715.9922.2915.9527.65
Upgrade
PB Ratio
0.344.902.79-1.69-5.247.68
Upgrade
P/TBV Ratio
0.375.202.92--10.36
Upgrade
EV/Sales Ratio
-5.4824.8133.0918.1223.33
Upgrade
Debt / Equity Ratio
----1.23-2.32-
Upgrade
Asset Turnover
0.810.460.240.170.240.18
Upgrade
Inventory Turnover
1.872.281.081.252.89-
Upgrade
Quick Ratio
1.185.1913.619.821.663.57
Upgrade
Current Ratio
2.336.2314.6911.481.844.17
Upgrade
Return on Equity (ROE)
-122.53%-67.17%----153.69%
Upgrade
Return on Assets (ROA)
-59.00%-36.64%-51.03%-85.28%-93.75%-86.53%
Upgrade
Return on Capital Employed (ROCE)
-205.00%-93.80%-60.20%-172.10%-236.80%-210.30%
Upgrade
Earnings Yield
-657.02%-20.02%-56.63%-43.28%-50.29%-26.77%
Upgrade
FCF Yield
-465.29%-18.49%-20.58%-35.41%-35.13%-25.25%
Upgrade
Buyback Yield / Dilution
-10.06%-83.31%-5.73%--2.04%-12.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.